| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |